AMAGX
Price
$80.59
Change
+$0.51 (+0.64%)
Updated
Jun 6 closing price
Net Assets
5.34B
GAFFX
Price
$78.67
Change
+$0.76 (+0.98%)
Updated
Jun 6 closing price
Net Assets
307.78B
Interact to see
Advertisement

AMAGX vs GAFFX

Header iconAMAGX vs GAFFX Comparison
Open Charts AMAGX vs GAFFXBanner chart's image
Amana Growth Investor
Price$80.59
Change+$0.51 (+0.64%)
VolumeN/A
Net Assets5.34B
American Funds Growth Fund of Amer F3
Price$78.67
Change+$0.76 (+0.98%)
VolumeN/A
Net Assets307.78B
AMAGX vs GAFFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMAGX vs. GAFFX commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMAGX is a Buy and GAFFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 308B vs. AMAGX (5.34B). GAFFX pays higher dividends than AMAGX: GAFFX (0.65) vs AMAGX (0.00). AMAGX was incepted earlier than GAFFX: AMAGX (31 years) vs GAFFX (8 years). AMAGX (0.87) is less costly to investors than GAFFX (0.30). GAFFX is a more actively managed with annual turnover of: 25.00 vs. AMAGX (10.00). AMAGX has a lower initial minimum investment than GAFFX: AMAGX (100) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 9.74 vs. AMAGX (-0.04). AMAGX return over 5 years is better than : 72.21 vs. GAFFX (47.05).
AMAGXGAFFXAMAGX / GAFFX
Total Expense Ratio0.870.30290%
Annual Report Gross Expense Ratio0.870.30290%
Fund Existence31 years8 years-
Gain YTD0.6925.64012%
Front LoadN/AN/A-
Min. Initial Investment10010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.34B308B2%
Annual Yield % from dividends0.000.65-
Returns for 1 year-0.049.74-0%
Returns for 3 years31.7638.5682%
Returns for 5 years72.2147.05153%
Returns for 10 years138.20N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KALV14.360.56
+4.09%
KalVista Pharmaceuticals
BRC70.000.45
+0.65%
Brady Corp
PKX47.710.03
+0.06%
POSCO Holdings
SLS1.61-0.02
-1.23%
SELLAS Life Sciences Group
CNET1.26-0.06
-4.56%
ZW Data Action Technologies Inc